作为新型抗微生物药物的植物性毒性制止药物:临床使用中的发现,前景和挑战
Lan Lu1, Jingya Wang1, Chongrui Wang2
1Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, Sichuan, P.R. China.
植物性天然产品提供有前途的毒性抑制药物 (VADs) 来对抗抗菌素耐药性 (AMR). 本综述探讨了VAD作为对抗多药耐药细菌病原体的抗病毒策略.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球公共卫生的重大威胁,需要新的治疗方法.
- 耐多药性细菌感染需要除了传统抗生素之外的替代治疗方法.
- 针对细菌毒性因素的抗病毒策略提供了一个有希望的替代方案,以规避AMR.
研究的目的:
- 审查植物性天然产品作为潜在的毒性抑制药物 (VADs).
- 总结细菌毒性因素及其在感染中的作用.
- 讨论VADs的临床和专利环境以及未来的前景.
主要方法:
- 关于科学数据库和专利存储库的文献评论.
- 对具有已证明抗病毒活性的植物性化合物的分析.
- 综合VAD,临床试验,专利和基因组学引导的发现信息.
主要成果:
- 植物性天然产品是VAD候选物的丰富来源.
- 确定了各种细菌毒性因素及其作用机制.
- 总结了VAD开发,临床试验和专利方面的最新进展.
结论:
- 植物衍生VADs代表了一种可持续的策略来打击AMR.
- 需要进一步的研究和开发,以克服临床应用中的挑战.
- 基因组学引导的方法可以加速发现新的VAD治疗方法.
更多相关视频
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
08:39Live-cell Imaging of Fungal Cells to Investigate Modes of Entry and Subcellular Localization of Antifungal Plant Defensins
Published on: December 24, 2017
相关概念视频
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defenses Against Pathogens and Herbivores
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drugs that Destabilize Microtubules
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
